EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,284 | -11.1% | 13,725 | -27.1% | 0.01% | -33.3% |
| Q3 2022 | $295,000 | -46.8% | 18,828 | -29.4% | 0.01% | -45.5% |
| Q2 2022 | $555,000 | +107.1% | 26,683 | +125.3% | 0.02% | +144.4% |
| Q1 2022 | $268,000 | +24.1% | 11,842 | -0.1% | 0.01% | 0.0% |
| Q4 2021 | $216,000 | -97.8% | 11,856 | -98.2% | 0.01% | -97.8% |
| Q4 2016 | $9,888,000 | -3.5% | 663,180 | -17.2% | 0.40% | +22.4% |
| Q3 2016 | $10,245,000 | +1503.3% | 800,980 | +371.2% | 0.33% | +842.9% |
| Q2 2015 | $639,000 | – | 170,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |